Skip to content

Biomarkers in Prediction of AMI

Biomarkers In Prediction of Acute Mesenteric Ischaemia: a Prospective Multicentre Study (BIPAMI Study)

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06212921
Acronym
BIPAMI
Enrollment
250
Registered
2024-01-19
Start date
2024-10-14
Completion date
2025-12-31
Last updated
2024-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Mesenteric Ischemia

Brief summary

Current study will be undertaken to identify combinations of biomarkers that can reliably identify acute mesenteric ischaemia (AMI) and distinguish between non-transmural and transmural ischaemia. Different combinations of biomarkers for different sub-types and severity of AMI, and different time points of measurement after onset of symptoms.

Interventions

DIAGNOSTIC_TESTSequential blood samples

Sequential blood samples for diagnostic tests is the only intervention in thei study

Sponsors

University of Tartu
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

Sequential blood samples will be collected from study subjects

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 years or older * Initial decision in favour of further diagnostics of mesenteric ischaemia

Exclusion criteria

* Age \<18 years * Consent declined by patient or next of kin (delayed consent) * Chronic mesenteric ischaemia without an acute event * Immediate decision for withdrawal of further diagnostics and active treatment * Referral from another hospital with already established diagnosis of AMI * AMI diagnosed at surgery without previously having been considered

Design outcomes

Primary

MeasureTime frameDescription
Rate of correctly predicted cases of acute mesenteric ischaemia10 monthsRate of correctly predicted cases of Acute mesenteric ischaemia using different biomarkers

Countries

Estonia, Switzerland

Contacts

Primary ContactAnnika Reintam Blaser, PhD
annika.reintam.blaser@ut.ee+3725142281

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026